A Long-term Safety Study With Tapentadol ER and Oxycodone CR in Patients With Moderate to Severe Pain Due to Chronic, Painful Diabetic Peripheral Neuropathy (DPN)

Clinical trial NCT01063868 · TERMINATED

Trial details

NCT number: NCT01063868
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetic Neuropathy, Painful Diabetic Polyneuropathy

Start date: 2010-01-01
Primary completion: 2010-04-01
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.